Long-term, low-dose lithium treatment does not impair renal function in the elderly: A 2-year randomized, placebo-controlled trial followed by single-blind extension

Journal of Clinical Psychiatry

Volumn 75, Issue 7, 2014, Pages

  Aprahamian, Ivan ^a   Santos, Franklin S ^a   Dos Santos, Bernardo ^a   Talib, Leda ^a   Diniz, Breno S ^a   Radanovic, Márcia ^a   Gattaz, Wagner F ^a   Forlenza, Orestes V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; GLUCOSE; INSULIN; LITHIUM CARBONATE; PLACEBO; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; BODY WEIGHT; BODY WEIGHT DISORDER; CHRONIC DRUG ADMINISTRATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUTROPHIL COUNT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THYROID DISEASE; THYROID GLAND; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; UKU SIDE EFFECT RATING SCALE; WEIGHT GAIN;

AGED; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY DISEASES; LITHIUM; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; MILD COGNITIVE IMPAIRMENT; PLACEBOS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84902669147     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08741     Document Type: Article

References (29)

1. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217-222. doi:10.176/api.ajp.161.2.217 PubMed (Pubitemid 38419270)
2. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162(10):1805-1819. doi:10.176/api.ajp.162.10.1805 PubMed (Pubitemid 41428610)
3. Ohgami H, Terao T, Shiotsuki I, et al. Lithium levels in drinking water and risk of suicide. Br J Psychiatry. 2009;194(5):464-465, discussion 446. doi:10.192/bjp.bp.108.05798 PubMed
4. Forlenza OV, Diniz BS, Radanovic M, et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry. 2011;198(5):351-356. doi:10.192/bjp.bp.10.0804 PubMed
5. Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use? Br J Psychiatry. 2007;191(6):474-476. doi:10.192/bjp.bp. 107.04313 PubMed (Pubitemid 350273206)
6. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach, part 3: clinical safety. CNS Drugs. 2009;23(5):397-418. doi:10.2165/023210-20923050-04 PubMed
7. Paul R, Minay J, Cardwell C, et al. Meta-analysis of the effects of lithium usage on serum creatinine levels. J Psychopharmacol. 2010;24(10):1425-1431. doi:10.17/02698109104930 PubMed
8. McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721-728. doi:10.1016/S0140-6736(1)61516-X PubMed
9. Presne C, Fakhouri F, Noël LH, et al. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 2003;64(2):585-592. doi:10.1046/j.1523-175.203.096.x PubMed (Pubitemid 36871930)
10. Bendz H, Sjödin I, Aurell M. Renal function on and off lithium in patients treated with lithium for 15 years or more: a controlled, prospective lithium-withdrawal study. Nephrol Dial Transplant. 1996;11(3):457-460. doi:10.1093/oxfordjournals.ndt.a02731 PubMed (Pubitemid 26093740)
11. Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. Eur Psychiatry. 2001;16(4):199-206. doi:10.1016/S0924-938(01)0565-X PubMed (Pubitemid 32591790)
12. Bassilios N, Martel P, Godard V, et al; Réseau Néphropar. Monitoring of glomerular filtration rate in lithium-treated outpatients-an ambulatory laboratory database surveillance. Nephrol Dial Transplant. 2008;23(2):562-565. doi:10.1093/ndt/gfm567 PubMed (Pubitemid 351767609)
13. McCann SM, Daly J, Kelly CB. The impact of long-term lithium treatment on renal function in an outpatient population. Ulster Med J. 2008;77(2):102-105. PubMed (Pubitemid 351756785)
14. Janowsky DS, Soares J, Hatch JP, et al. Lithium effect on renal glomerular function in individuals with intellectual disability. J Clin Psychopharmacol. 2009;29(3):296-299. doi:10.1097/JCP.0b013e3181a5dcb7 PubMed
15. Lepkifker E, Sverdlik A, Iancu I, et al. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry. 2004;65(6):850-856. doi:10.408/JCP. v65n0618 PubMed
16. Macdonald A, Briggs K, Poppe M, et al. A feasibility and tolerability study of lithium in Alzheimer's disease. Int J Geriatr Psychiatry. 2008;23(7):704-711. doi:10.102/gps.1964 PubMed
17. Hampel H, Ewers M, Bürger K, et al. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry. 2009;70(6):922-931. doi:10.408/JCP.08m04606 PubMed
18. Diniz BS, Nunes PV, Yassuda MS, et al. Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr. 2008;30(4):316-321. doi:10.1590/S1516-462080403 PubMed
19. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308. doi:10.101/archneur.56.3.303 PubMed (Pubitemid 29120227)
20. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand suppl. 1987;76(s334):1-100. doi:10.1/j.160-047.1987.tb1056.x PubMed (Pubitemid 17115352)
21. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens. 2008;17(6):604-608. doi:10.1097/MNH.0b013e32830f454e PubMed
22. Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012;156(11):785-795, W-270, W-271, W-272, W-273, W-274, W-275, W-276, W-277, W-278. doi:10.7326/03-4819-156-1-20120320-0391 PubMed
23. Morriss R, Benjamin B. Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. Br J Psychiatry. 2008;193(2):93-95. doi:10.192/bjp.bp.108.051268 PubMed
24. Hullin RP, Coley VP, Birch NJ, et al. Renal function after long-term treatment with lithium. BMJ. 1979;1(6176):1457-1459. doi:10.136/bmj.1.6176.1457 PubMed (Pubitemid 9202379)
25. Coşkunol H, Vahip S, Mees ED, et al. Renal side-effects of long-term lithium treatment. J Affect Disord. 1997;43(1):5-10. doi:10.1016/S0165-0327(96)046-8 PubMed (Pubitemid 27146243)
26. Turan T, Eşel E, Tokgöz B, et al. Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(3):561-565. doi:10.1016/S0278-5846(01)0308-6 PubMed (Pubitemid 34252951)
27. Bendz H. Kidney function in a selected lithium population: a prospective, controlled, lithium-withdrawal study. Acta Psychiatr Scand. 1985;72(5):451-463. doi:10.1/j.160-047.1985.tb02639.x PubMed (Pubitemid 16173563)
28. Hetmar O, Clemmesen L, Ladefoged J, et al. Lithium: long-term effects on the kidney, 3: prospective study. Acta Psychiatr Scand. 1987;75(3):251-258. doi:10.1/j.160-047.1987.tb02785.x PubMed (Pubitemid 17041501)
29. Vestergaard P, Schou M. Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology. 1987;17(3):130-132. doi:10.159/018351 PubMed (Pubitemid 17142727)